Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Treatment of recurrent hepatitis C in liver transplant recipients: is there any histologic benefit?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Treatment of recurrent hepatitis C in liver transplant recipients: is there any histologic benefit?
Treatment of recurrent hepatitis C in liver transplant recipients: is there any histologic benefit? Liver Transpl. 2003 Apr; 9(4):354-9.
View in:
PubMed
subject areas
Adult
Antiviral Agents
Disease Progression
Drug Administration Schedule
Drug Therapy, Combination
Female
Hepatitis C
Humans
Interferon-alpha
Liver
Liver Cirrhosis
Liver Transplantation
Male
Middle Aged
Recombinant Proteins
Recurrence
Retrospective Studies
Ribavirin
Treatment Failure